Correlation Between Apellis Pharmaceuticals and ATyr Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and ATyr Pharma, you can compare the effects of market volatilities on Apellis Pharmaceuticals and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and ATyr Pharma.

Diversification Opportunities for Apellis Pharmaceuticals and ATyr Pharma

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Apellis and ATyr is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and ATyr Pharma go up and down completely randomly.

Pair Corralation between Apellis Pharmaceuticals and ATyr Pharma

If you would invest  2,798  in Apellis Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of  595.00  from holding Apellis Pharmaceuticals or generate 21.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Apellis Pharmaceuticals  vs.  ATyr Pharma

 Performance 
       Timeline  
Apellis Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apellis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
ATyr Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ATyr Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, ATyr Pharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Apellis Pharmaceuticals and ATyr Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apellis Pharmaceuticals and ATyr Pharma

The main advantage of trading using opposite Apellis Pharmaceuticals and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.
The idea behind Apellis Pharmaceuticals and ATyr Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios